BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26872615)

  • 1. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
    Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
    J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
    Sun M; Chen Y; Liu X; Cui Y
    Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-23b suppresses lung carcinoma cell proliferation through CCNG1.
    Han H; Zhang Z; Yang X; Yang W; Xue C; Cao X
    Oncol Lett; 2018 Oct; 16(4):4317-4324. PubMed ID: 30214567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
    Liu Y; Fu X; Wang X; Liu Y; Song X
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
    Xu Y; Zhang Q; Miao C; Dongol S; Li Y; Jin C; Dong R; Li Y; Yang X; Kong B
    Cancer Med; 2019 Jan; 8(1):351-362. PubMed ID: 30565428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
    Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
    Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells.
    Wu B; Xing C; Tao J
    J Orthop Surg Res; 2019 Nov; 14(1):398. PubMed ID: 31779647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
    Liu X; Ma L; Rao Q; Mao Y; Xin Y; Xu H; Li C; Wang X
    Med Sci Monit; 2015 Oct; 21():3152-8. PubMed ID: 26477861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
    Liu CH; Jing XN; Liu XL; Qin SY; Liu MW; Hou CH
    J Ovarian Res; 2020 Aug; 13(1):92. PubMed ID: 32782028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
    Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
    Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-488 inhibits ovarian cancer cell metastasis through regulating CCNG1 and p53 expression.
    Guo JY; Wang XQ; Sun LF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2902-2910. PubMed ID: 32271408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1.
    Han S; Zhu J; Zhang Y
    Med Sci Monit Basic Res; 2018 Feb; 24():40-46. PubMed ID: 29445078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.